Literature DB >> 21643937

Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry.

Mikael Schneider1, Ditte Caroline Andersen, Asli Silahtaroglu, Stig Lyngbæk, Sakari Kauppinen, Jakob Lerche Hansen, Søren Paludan Sheikh.   

Abstract

MicroRNAs (miRNAs) regulate gene expression by mediating translational repression or mRNA degradation of their targets, and several miRNAs control developmental decisions through embryogenesis. In the developing heart, miRNA targets comprise key players mediating cardiac lineage determination. However, although several miRNAs have been identified as differentially regulated during cardiac development and disease, their distinct cell-specific localization remains largely undetermined, likely owing to a lack of adequate methods. We therefore report the development of a markedly improved approach combining fluorescence-based miRNA-in situ hybridization (miRNA-ISH) with immunohistochemistry (IHC). We have applied this protocol to differentiating embryoid bodies (EBs) as well as embryonic and adult mouse hearts, to detect miRNAs that were upregulated during EB cardiomyogenesis, as determined by array-based miRNA expression profiling. In this manner, we found specific co-localization of miR-1 to myosin positive cells (cardiomyocytes) of EBs, developing and mature hearts. In contrast, miR-125b and -199a did not localize to cardiomyocytes, as previously suggested for miR-199a, but were rather expressed in connective tissue cells of the heart. More specifically, by co-staining with α-smooth muscle actin (α-SMA) and collagen-I, we found that miR-125b and -199a localize to perivascular α-SMA(-) stromal cells. Our approach thus proved valid for determining cell-specific localization of miRNAs, and the findings we present highlight the importance of determining exact cell-specific localization of miRNAs by sequential miRNA-ISH and IHC in studies aiming at understanding the role of miRNAs and their targets. This approach will hopefully aid in identifying relevant miRNA targets of both the heart and other organs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643937     DOI: 10.1007/s10735-011-9332-8

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  31 in total

Review 1.  Embryonic stem cell differentiation: emergence of a new era in biology and medicine.

Authors:  Gordon Keller
Journal:  Genes Dev       Date:  2005-05-15       Impact factor: 11.361

2.  An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133.

Authors:  Ning Liu; Andrew H Williams; Yuri Kim; John McAnally; Svetlana Bezprozvannaya; Lillian B Sutherland; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

3.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

4.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

5.  Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes.

Authors:  Shweta Rane; Minzhen He; Danish Sayed; Himanshu Vashistha; Ashwani Malhotra; Junichi Sadoshima; Dorothy E Vatner; Stephen F Vatner; Maha Abdellatif
Journal:  Circ Res       Date:  2009-03-05       Impact factor: 17.367

6.  A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets.

Authors:  Gerard J Nuovo; Terry S Elton; Patrick Nana-Sinkam; Stefano Volinia; Carlo M Croce; Thomas D Schmittgen
Journal:  Nat Protoc       Date:  2009-01-08       Impact factor: 13.491

7.  MicroRNA regulation of cell lineages in mouse and human embryonic stem cells.

Authors:  Kathryn N Ivey; Alecia Muth; Joshua Arnold; Frank W King; Ru-Fang Yeh; Jason E Fish; Edward C Hsiao; Robert J Schwartz; Bruce R Conklin; Harold S Bernstein; Deepak Srivastava
Journal:  Cell Stem Cell       Date:  2008-03-06       Impact factor: 24.633

8.  Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes.

Authors:  Mark Aplin; Gitte Lund Christensen; Mikael Schneider; Arne Heydorn; Steen Gammeltoft; Anne Louise Kjølbye; Søren P Sheikh; Jakob Lerche Hansen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2007-05       Impact factor: 4.080

9.  MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?

Authors:  Yunhui Cheng; Ruirui Ji; Junming Yue; Jian Yang; Xiaojun Liu; He Chen; David B Dean; Chunxiang Zhang
Journal:  Am J Pathol       Date:  2007-06       Impact factor: 4.307

10.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.

Authors:  Jo Vandesompele; Katleen De Preter; Filip Pattyn; Bruce Poppe; Nadine Van Roy; Anne De Paepe; Frank Speleman
Journal:  Genome Biol       Date:  2002-06-18       Impact factor: 13.583

View more
  12 in total

Review 1.  Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer.

Authors:  Lorenzo F Sempere
Journal:  Expert Rev Mol Diagn       Date:  2011-11       Impact factor: 5.225

Review 2.  OxymiRs in cutaneous development, wound repair and regeneration.

Authors:  Chandan K Sen; Sashwati Roy
Journal:  Semin Cell Dev Biol       Date:  2012-10-10       Impact factor: 7.727

Review 3.  Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases.

Authors:  Masaru Katoh
Journal:  Front Cell Dev Biol       Date:  2014-10-16

4.  Two-Color-Based Nanoflares for Multiplexed MicroRNAs Imaging in Live Cells.

Authors:  Jing Li; Jin Huang; Xiaohai Yang; Yanjing Yang; Ke Quan; Nuli Xie; Yanan Wu; Changbei Ma; Kemin Wang
Journal:  Nanotheranostics       Date:  2018-01-01

Review 5.  Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a.

Authors:  Shen Gu; Wai-Yee Chan
Journal:  Int J Mol Sci       Date:  2012-07-09       Impact factor: 6.208

6.  Molecular targeting of NOX4 for neuropathic pain after traumatic injury of the spinal cord.

Authors:  Y B Im; M K Jee; J I Choi; H T Cho; O H Kwon; S K Kang
Journal:  Cell Death Dis       Date:  2012-11-15       Impact factor: 8.469

7.  Combined fluorescent in situ hybridization for detection of microRNAs and immunofluorescent labeling for cell-type markers.

Authors:  Amrita D Chaudhuri; Sowmya V Yelamanchili; Howard S Fox
Journal:  Front Cell Neurosci       Date:  2013-09-23       Impact factor: 5.505

Review 8.  Tissue slide-based microRNA characterization of tumors: how detailed could diagnosis become for cancer medicine?

Authors:  Lorenzo F Sempere
Journal:  Expert Rev Mol Diagn       Date:  2014-08-04       Impact factor: 5.225

Review 9.  Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling.

Authors:  Dmitry A Chistiakov; Igor A Sobenin; Alexander N Orekhov; Yuri V Bobryshev
Journal:  Biomed Res Int       Date:  2015-06-29       Impact factor: 3.411

10.  Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor.

Authors:  Hiroyuki Minemura; Kiyoshi Takagi; Yasuhiro Miki; Yukiko Shibahara; Saki Nakagawa; Akiko Ebata; Mika Watanabe; Takanori Ishida; Hironobu Sasano; Takashi Suzuki
Journal:  Cancer Sci       Date:  2015-10-07       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.